MicroRNA-34a Regulates High Glucose-induced Apoptosis in H9c2 Cardiomyocytes

Overview

Journal J Huazhong Univ Sci Technolog Med Sci

Specialty General Medicine

Date 2013 Dec 17

PMID 24337844

Citations 27

Authors

Fang Zhao

Bo Li

Yin-Zhi Wei

Bin Zhou

Han Wang

Ming Chen

Xue-Dong Gan

Zhao-Hui Wang

Shi-Xi Xiong

Affiliations

Soon will be listed here.

Abstract

Hyperglycemia is an important initiator of cardiovascular disease, contributing to the development of cardiomyocyte death and diabetic complications. The purpose of the present study was to investigate whether high glucose state could induce apoptosis of rat cardiomyocyte cell line H9c2 through microRNA-mediated Bcl-2 signaling pathway. The expression of miR-34a and Bcl-2 mRNA was detected by using real-time PCR. Western blotting was used to examine the changes in apoptosis-associated protein Bcl-2. Apoptosis of H9c2 cells was tested by using flow cytometry. The results showed that the expression of miR-34a was significantly elevated and that of Bcl-2 was strongly reduced, and apoptosis of cardiomyocytes was apparently increased in the high-glucose-treated H9c2 cells as compared with normal-glucose-treated controls. In addition, we identified Bcl-2 gene was the target of miR-34a. miR-34a mimics reduced the expression of Bcl-2 and increased glucose-induced apoptosis, but miR-34a inhibitor acted as the opposite mediator. Our data demonstrate that miR-34a contributes to high glucose-induced decreases in Bcl-2 expression and subsequent cardiomyocyte apoptosis.

Citing Articles

The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy.

Wu H, Liu Y, Liu C Noncoding RNA Res. 2024; 9(4):1080-1097.

PMID: 39022683 PMC: 11254508. DOI: 10.1016/j.ncrna.2024.06.011.

Roles of non-coding RNA in diabetic cardiomyopathy.

Yao X, Huang X, Chen J, Lin W, Tian J Cardiovasc Diabetol. 2024; 23(1):227.

PMID: 38951895 PMC: 11218407. DOI: 10.1186/s12933-024-02252-9.

MicroRNAs Targeting Critical Molecular Pathways in Diabetic Cardiomyopathy Emerging Valuable for Therapy.

Mathur P, Saxena S, Saxena B, Rani V Cardiovasc Hematol Agents Med Chem. 2024; 22(3):298-307.

PMID: 38265401 DOI: 10.2174/0118715257265947231129074526.

Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy.

Potel K, Cornelius V, Yacoub A, Chokr A, Donaghy C, Kelaini S Front Cardiovasc Med. 2023; 10:1165302.

PMID: 37719978 PMC: 10502732. DOI: 10.3389/fcvm.2023.1165302.

What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review.

Lou X, Zhang Y, Guo J, Gao L, Ding Y, Zhuo X Heart Fail Rev. 2023; 29(1):1-11.

PMID: 37555989 DOI: 10.1007/s10741-023-10336-z.

References

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

Bertoni A, Hundley W, Massing M, Bonds D, Burke G, Goff Jr D . Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004; 27(3):699-703. DOI: 10.2337/diacare.27.3.699. View

Rota M, LeCapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas M . Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res. 2006; 99(1):42-52. DOI: 10.1161/01.RES.0000231289.63468.08. View

Katare R, Caporali A, Zentilin L, Avolio E, Sala-Newby G, Oikawa A . Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res. 2011; 108(10):1238-51. DOI: 10.1161/CIRCRESAHA.110.239111. View

Ito T, Yagi S, Yamakuchi M . MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun. 2010; 398(4):735-40. DOI: 10.1016/j.bbrc.2010.07.012. View

RUBLER S, Dlugash J, YUCEOGLU Y, Kumral T, BRANWOOD A, GRISHMAN A . New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972; 30(6):595-602. DOI: 10.1016/0002-9149(72)90595-4. View

Welch C, Chen Y, Stallings R . MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007; 26(34):5017-22. DOI: 10.1038/sj.onc.1210293. View

Fein F . Diabetic cardiomyopathy. Diabetes Care. 1990; 13(11):1169-79. DOI: 10.2337/diacare.13.11.1169. View

Bommer G, Gerin I, Feng Y, Kaczorowski A, Kuick R, Love R . p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007; 17(15):1298-307. DOI: 10.1016/j.cub.2007.06.068. View

10.

Van Rooij E, Sutherland L, Qi X, Richardson J, Hill J, Olson E . Control of stress-dependent cardiac growth and gene expression by a microRNA. Science. 2007; 316(5824):575-9. DOI: 10.1126/science.1139089. View

11.

Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y . Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2010; 48(1):61-9. DOI: 10.1007/s00592-010-0226-0. View

12.

Williams A, Liu N, Van Rooij E, Olson E . MicroRNA control of muscle development and disease. Curr Opin Cell Biol. 2009; 21(3):461-9. PMC: 2692369. DOI: 10.1016/j.ceb.2009.01.029. View

13.

Miranda K, Huynh T, Tay Y, Ang Y, Tam W, Thomson A . A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006; 126(6):1203-17. DOI: 10.1016/j.cell.2006.07.031. View

14.

Van Rooij E, Olson E . MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007; 117(9):2369-76. PMC: 1952642. DOI: 10.1172/JCI33099. View

15.

Hermeking H . The miR-34 family in cancer and apoptosis. Cell Death Differ. 2009; 17(2):193-9. DOI: 10.1038/cdd.2009.56. View

16.

McKinsey T, Olson E . Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest. 2005; 115(3):538-46. PMC: 1052006. DOI: 10.1172/JCI24144. View

17.

Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12(9):735-9. DOI: 10.1016/s0960-9822(02)00809-6. View

18.

Yoon Y, Uchida S, Masuo O, Cejna M, Park J, Gwon H . Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after.... Circulation. 2005; 111(16):2073-85. DOI: 10.1161/01.CIR.0000162472.52990.36. View

19.

Reed J, MEISTER L, Tanaka S, Cuddy M, Yum S, Geyer C . Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 1991; 51(24):6529-38. View

20.

Van Rooij E, Sutherland L, Liu N, Williams A, McAnally J, Gerard R . A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-60. PMC: 1838739. DOI: 10.1073/pnas.0608791103. View